We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.25B
AUM Growth
+$238M
Cap. Flow
+$171M
Cap. Flow %
13.68%
Top 10 Hldgs %
33.92%
Holding
174
New
8
Increased
66
Reduced
28
Closed
10

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$16M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.1M
3
STX icon
Seagate
STX
+$10.8M
4
SWKS icon
Skyworks Solutions
SWKS
+$8.56M
5
INTC icon
Intel
INTC
+$7.85M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$16.6M
2
NVDA icon
NVIDIA
NVDA
+$3.75M
3
CRM icon
Salesforce
CRM
+$3.04M
4
STJ
St Jude Medical
STJ
+$2.53M
5
NOC icon
Northrop Grumman
NOC
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 36.82%
2 Financials 20.37%
3 Communication Services 12.74%
4 Healthcare 12.48%
5 Consumer Discretionary 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPG
76
DELISTED
Interpublic Group of Companies
IPG
$3.82M 0.31%
155,495
+22,345
+17% +$536K
WAT icon
77
Waters Corp
WAT
$36.8B
$3.78M 0.3%
24,200
– –
RIG icon
78
Transocean
RIG
$5.92B
$3.58M 0.29%
287,214
-990
-0.3% -$13.6K
BIIB icon
79
Biogen
BIIB
$29.9B
$3.57M 0.29%
13,070
+4,690
+56% +$1.33M
BDX icon
80
Becton Dickinson
BDX
$43.1B
$3.48M 0.28%
19,475
– –
BCR
81
DELISTED
CR Bard Inc.
BCR
$3.46M 0.28%
13,915
– –
MRVL icon
82
Marvell Technology
MRVL
$174B
$3.18M 0.25%
208,400
– –
MRK icon
83
Merck
MRK
$324B
$3.11M 0.25%
51,352
-2,410
-4% -$146K
WDC icon
84
Western Digital
WDC
$179B
$3.09M 0.25%
49,474
-28,808
-37% -$1.65M
DGX icon
85
Quest Diagnostics
DGX
$25.1B
$3.05M 0.24%
31,100
-600
-2% -$57.2K
SNY icon
86
Sanofi
SNY
$104B
$2.95M 0.24%
65,200
– –
NBR icon
87
Nabors Industries
NBR
$1.23B
$2.9M 0.23%
4,446
+60
+1% +$45.9K
UNH icon
88
UnitedHealth
UNH
$382B
$2.77M 0.22%
16,900
-200
-1% -$32.8K
JNJ icon
89
Johnson & Johnson
JNJ
$635B
$2.7M 0.22%
21,700
– –
CRUS icon
90
Cirrus Logic
CRUS
$6.74B
$2.67M 0.21%
44,050
-800
-2% -$45.6K
CRL icon
91
Charles River Laboratories
CRL
$10.9B
$2.59M 0.21%
28,750
-1,650
-5% -$140K
AET
92
DELISTED
Aetna Inc
AET
$2.57M 0.21%
20,160
– –
VVX icon
93
V2X
VVX
$2.62B
$2.51M 0.2%
112,459
+280
+0.2% +$6.42K
WOOF
94
DELISTED
VCA Inc.
WOOF
$2.35M 0.19%
25,700
– –
SYK icon
95
Stryker
SYK
$127B
$2.28M 0.18%
17,310
-2,990
-15% -$378K
ENDP
96
DELISTED
Endo International plc
ENDP
$2.13M 0.17%
191,185
+52,615
+38% +$654K
CI icon
97
Cigna
CI
$76.6B
$2.05M 0.16%
14,000
– –
GSBC icon
98
Great Southern Bancorp
GSBC
$863M
$1.98M 0.16%
39,257
-2,295
-6% -$117K
FTNT icon
99
Fortinet
FTNT
$112B
$1.95M 0.16%
254,175
– –
LLY icon
100
Eli Lilly
LLY
$1.07T
$1.89M 0.15%
22,500
– –
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Oak Associates held 174 positions worth $1.25B, up 24% from $1.01B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Oak Associates deployed $171M of net new capital in Q1 2017, opening 8 new positions and adding to 66 existing holdings. Its largest new stake was CVS Health: 200,380 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $16.6M trimmed.

  • Oak Associates's largest Q1 2017 buy was CVS Health: 200,380 shares worth $15.7M.
  • Oak Associates added most to Alphabet (Google) Class C in Q1 2017, an estimated $11.1M increase.
  • Oak Associates's biggest Q1 2017 reduction was JPMorgan Chase, cutting an estimated $16.6M.
  • Oak Associates fully exited St Jude Medical in Q1 2017, selling an estimated $2.53M.
  • Oak Associates's ten largest holdings make up 34% of its $1.25B portfolio in Q1 2017.
  • Oak Associates opened 8 new positions and closed 10 in Q1 2017.
  • Oak Associates's portfolio value rose 24% quarter-over-quarter to $1.25B.

Based on Oak Associates's 13F filing for Q1 2017, filed 16 May 2017.